All
Search
Images
Videos
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Phase 3 VIKTORIA-2 Study: Fulvestrant & CDK4/6i /- Gedatolis
…
1 month ago
vumedi.com
SABCS 2023 Insights: "VIKTORIA-1 Study of Gedatolisib Fulvestrant /
…
376 views
Dec 12, 2023
vumedi.com
Celcuity Inc.: Celcuity Announces First Patient Dosed in Phase 3 VIK
…
5 months ago
finanznachrichten.de
Dr Han on the Investigation of Gedatolisib in HR /HER2– Metastat
…
Apr 26, 2023
onclive.com
5:33
Gedatolisib in HR+/HER2-, PIK3CA-WT Breast Cancer: A New SOC in
…
3 weeks ago
YouTube
Open World Collective
Dr McCann on the Potential Clinical Utility of Gedatolisib in Advanced
…
2 months ago
onclive.com
Celcuity Inc.: Celcuity Presents Overall Survival Data from Phase
…
1 month ago
finanznachrichten.de
Celcuity Inc. finalise le dépôt de sa demande d'autorisation de mise s
…
1 month ago
zonebourse.com
1:07:55
PI3K/ AKT/mTOR Pathway Inhibitors in the Treatment of HR+/HER2- Me
…
2 months ago
YouTube
CancerNet Events
Updates from ESMO: New findings from the VIKTORIA-1 phase III tria
…
849 views
2 months ago
Facebook
OWise Breast Cancer
0:15
Gedatolisib Regimens Significantly Extend Survival in Advanced Brea
…
10 views
2 months ago
YouTube
Jh Li
HR /HER2- Breast Cancer: Inhibiting the PI3K/AKT/mTOR Pathway | On
…
Aug 8, 2023
onclive.com
1:03
Gedatolisib y Darolutamida muestran eficacia en cáncer de pr
…
314 views
6 months ago
YouTube
CUAN Hospital - Centro de Urología Avanzada
1:24
ESMO 2025: breakthrough ADC trials in TNBC and HER2+ breast c
…
742 views
2 months ago
YouTube
VJOncology
4:43
PI3K Inhibitors in HR+ Metastatic Breast Cancer
1.5K views
Mar 3, 2017
YouTube
OncLive
23:34
Metastatic HR+ Breast Cancer SABCS 2025 Highlights: Dr. Hope
…
4.5K views
1 week ago
YouTube
OncBrothers: Practice-Changing Cancer Discus…
4:39
Oncology Update by LucidQuest Episode 30
13 views
4 months ago
YouTube
LucidQuest
8:23
Disitamab Vedotin Plus Pembrolizumab in aUC: HER2 Stat
…
228 views
Sep 18, 2024
YouTube
GU Oncology Now
4:38
How does sitagliptin work? DPP-4 inhibitors and GLP-1 mimetics
215.3K views
Dec 6, 2016
YouTube
Zero To Finals
Sotorasib vs. Adagrasib as Treatment for KRAS G12C Mutate
…
872 views
Apr 28, 2023
YouTube
Global Resource for Advancing Cancer Education
3:30
Dutasteride and Silodosin Tablet and Capsule - Drug Information
29.2K views
Apr 8, 2019
YouTube
Netmeds.com
0:20
Gepotidacin #newdrug #fdaapproved #uti #urinarytractinf
…
52 views
3 months ago
YouTube
Drug_doctor 💊⚕️
1:23
Phase II trial of telisotuzumab adizutecan in HER2- G/GEJ cance
…
59 views
7 months ago
YouTube
VJOncology
4:48
Patient Selection and Sequencing of NSCLC ADCs | OncLive
Aug 19, 2024
onclive.com
50:15
Anti GD2 Antibody Therapy - an important approach in the treatme
…
1.8K views
Nov 12, 2022
YouTube
Neuroblastoma Parent Symposium
B-cell Malignancies: Developing New Options to Meet Patient Needs
3 months ago
linkedin.com
5:16
Oncology Update – November 24, 2025: Keytruda SC EU Nod, Libtay
…
5 views
1 month ago
YouTube
LucidQuest
1:07
PD-L1 Test Key in First-Line TNBC Treatment: Sacituzumab vs Datop
…
43 views
1 month ago
YouTube
Innovative Oncology News
DOSTARLIMAB: The Breakthrough in Cancer Treatment
98.8K views
Jun 8, 2022
TikTok
theoncdoc
Dr Kopetz on the Future Utility of Adagrasib/Cetuximab in KRAS G1
…
Apr 30, 2024
onclive.com
See more videos
More like this
Feedback
Feedback